References
- 1. Baker GA, Jacoby A, Buck D, Stalgis C, Monet D. Quality of life of people with epilepsy: a European study. Epilepsia. 1997;38(3):353-62.
- 2. Cramer JA, Brandenburg NA, Xu X, Vera-Llonch M, Oster G. The impact of seizures and adverse effects on global health ratings. Epilepsy Behav. 2007;11(2):179-84.
- 3. Fisher RS, Vickrey BG, Gibson P, Hermann B, Penovich P, Scherer A et al. The impact of epilepsy from the patient's perspective II: views about therapy and health care. Epilepsy Res. 2000;41(1):53-61.
- 4. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology. 2002;58(Suppl. 5):9-19.
- 5. Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, et al. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consequtively enrolled patients using validated quantitative assessments. Epilepsia. 2011;52(12):2181-91.
- 6. May TW, Brandt C, Kassel J. Evaluation of a self-report questionnaire for the assessment of adverse effects of antiepileptic drugs. Epilepsia. 2009;50 (Suppl 4):104.
- 7. Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology. 2009;72(14):1223-9.
- 8. Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52(12):2168-80.
- 9. Nixon A, Kerr C, Breheny K, Wild D. Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements. Health Qual Life Outcomes. 2013;11:38.
- 10. Uijl SG, Uiterwaal CS, Aldenkamp AP, Carpay JA, Doelman JC, Keizer K, et al. A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with antiepileptic drugs. Seizure. 2006;15(4): 242–248.
- 11. Uijl SG, Uiterwaal CS., Aldenkamp AP, Carpay JA, Doelman JC, Keizer K, et al. Adjustment of treatment increases quality of life in patients with epilepsy: a randomized controlled pragmatic trial. Eur J Neurol. 2009;16(11):1173-7.
- 12. Viteva EI, Zachariev ZI, Semerdzhieva MA. Validation of the Bulgarian version of the quality of life in epilepsy inventory (QOLIE-89). Folia Med. 2010;52(1):34-9.
- 13. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16(3):297-334.
- 14. Nunnally JC, Bernstein IH. Psychometric theory. 3th ed. McGraw-Hill; 1994.
- 15. Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005;14:198-206.